دورية أكاديمية

Design and synthesis of atorvastatin derivatives with enhanced water solubility, hepatoselectivity and stability.

التفاصيل البيبلوغرافية
العنوان: Design and synthesis of atorvastatin derivatives with enhanced water solubility, hepatoselectivity and stability.
المؤلفون: Maklakova SY; Chemistry Department, Lomonosov Moscow State University GSP-1, Leninskie Gory 1/3 Moscow 119991 Russian Federation maklakovaSU@yandex.ru., Lopukhov AV; Chemistry Department, Lomonosov Moscow State University GSP-1, Leninskie Gory 1/3 Moscow 119991 Russian Federation maklakovaSU@yandex.ru., Khudyakov AD; Chemistry Department, Lomonosov Moscow State University GSP-1, Leninskie Gory 1/3 Moscow 119991 Russian Federation maklakovaSU@yandex.ru., Kovalev SV; Chemistry Department, Lomonosov Moscow State University GSP-1, Leninskie Gory 1/3 Moscow 119991 Russian Federation maklakovaSU@yandex.ru., Mazhuga MP; Chemistry Department, Lomonosov Moscow State University GSP-1, Leninskie Gory 1/3 Moscow 119991 Russian Federation maklakovaSU@yandex.ru., Chepikova OE; Department of Biotechnology, Sirius University of Science and Technology Olympic Avenue 1 Sochi 354340 Russian Federation., Zamyatnin AA Jr; Department of Biotechnology, Sirius University of Science and Technology Olympic Avenue 1 Sochi 354340 Russian Federation.; Institute of Molecular Medicine, Sechenov First Moscow State Medical University Trubetskaya Street 8/2 Moscow 119991 Russian Federation.; Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University GSP-1, Leninskie Gory Moscow 119992 Russian Federation.; Faculty of Health and Medical Sciences, University of Surrey Guildford GU2 7XH UK., Majouga AG; Chemistry Department, Lomonosov Moscow State University GSP-1, Leninskie Gory 1/3 Moscow 119991 Russian Federation maklakovaSU@yandex.ru.; Dmitry Mendeleev University of Chemical Technology of Russia Miusskaya Square 9 Moscow 125047 Russian Federation., Klyachko NL; Chemistry Department, Lomonosov Moscow State University GSP-1, Leninskie Gory 1/3 Moscow 119991 Russian Federation maklakovaSU@yandex.ru., Beloglazkina EK; Chemistry Department, Lomonosov Moscow State University GSP-1, Leninskie Gory 1/3 Moscow 119991 Russian Federation maklakovaSU@yandex.ru.
المصدر: RSC medicinal chemistry [RSC Med Chem] 2022 Oct 11; Vol. 14 (1), pp. 56-64. Date of Electronic Publication: 2022 Oct 11 (Print Publication: 2023).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Royal Society of Chemistry Country of Publication: England NLM ID: 101759460 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-8682 (Electronic) Linking ISSN: 26328682 NLM ISO Abbreviation: RSC Med Chem Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Cambridge : Royal Society of Chemistry, [2020]-
مستخلص: Statins are effective 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG-R) inhibitors, which are successfully used for cardiovascular disease treatment. Statins' side effects are generally attributed to poor bioavailability and hepatoselectivity, which are closely related to their high lipophilicity. Targeted delivery of statins to the liver is considered as a way to reduce unwanted side effects. Herein we report on synthesis and evaluation of atorvastatin conjugates targeting the galactose-specific hepatic asialoglycoprotein receptor (ASGPR). The prepared conjugates showed greater water solubility compared to unmodified atorvastatin. The synthesised compounds demonstrated potent binding to the ASGPR with submicromolar K D values. The conjugates with an amide bond connecting atorvastatin and the targeting moiety displayed the optimal stability under model conditions, as they underwent hydrolysis only when incubated with the intracellular protease. The hydrolysis products effectively inhibited HMG-R activity. The results suggest that the designed amide-based compounds have the potential to be further developed as orally administered prodrugs of atorvastatin.
Competing Interests: There are no conflicts to declare.
(This journal is © The Royal Society of Chemistry.)
References: J Med Chem. 1991 Jan;34(1):463-6. (PMID: 1992149)
J Am Chem Soc. 2017 Mar 8;139(9):3528-3536. (PMID: 28230359)
Enzyme Protein. 1996;49(1-3):94-105. (PMID: 8797000)
Bioorg Med Chem Lett. 2018 Feb 1;28(3):382-387. (PMID: 29269214)
J Med Chem. 2014 Jan 9;57(1):71-7. (PMID: 24341381)
J Control Release. 2015 Apr 10;203:126-39. (PMID: 25701309)
Drug Metab Dispos. 2006 Jul;34(7):1175-81. (PMID: 16624870)
Spectrochim Acta A Mol Biomol Spectrosc. 2016 Mar 5;156:155-63. (PMID: 26688207)
Chem Commun (Camb). 2011 Oct 7;47(37):10440-2. (PMID: 21842053)
Bioconjug Chem. 2020 May 20;31(5):1313-1319. (PMID: 32379426)
Nat Chem Biol. 2011 May 15;7(7):469-78. (PMID: 21572424)
Bioorg Med Chem Lett. 2018 Feb 1;28(3):503-508. (PMID: 29254645)
EMBO J. 1991 Sep;10(9):2321-30. (PMID: 1868826)
J Pharm Biomed Anal. 2017 Aug 5;142:7-14. (PMID: 28477451)
World J Hepatol. 2016 Aug 8;8(22):924-32. (PMID: 27574546)
Bioconjug Chem. 2021 Apr 21;32(4):763-781. (PMID: 33691403)
J Am Chem Soc. 2012 Feb 1;134(4):1978-81. (PMID: 22280495)
Bioorg Med Chem Lett. 2008 Feb 1;18(3):1151-6. (PMID: 18155906)
Toxicology. 2003 Jul 15;189(1-2):147-63. (PMID: 12821289)
Bioorg Med Chem. 2007 Aug 15;15(16):5576-89. (PMID: 17560788)
Xenobiotica. 2020 Mar;50(3):261-269. (PMID: 31173561)
Drug Discov Today. 2017 Oct;22(10):1572-1581. (PMID: 28676407)
Sci Rep. 2021 Mar 29;11(1):7114. (PMID: 33782486)
Curr Top Med Chem. 2011;11(18):2288-98. (PMID: 21671867)
Mol Pharm. 2021 Jan 4;18(1):461-468. (PMID: 33264010)
Bioorg Med Chem. 2019 Jun 1;27(11):2187-2191. (PMID: 31005367)
Biomed Res Int. 2014;2014:463895. (PMID: 24995297)
Endocrinol Metab Clin North Am. 2014 Dec;43(4):1007-33. (PMID: 25432394)
تواريخ الأحداث: Date Created: 20230210 Latest Revision: 20231012
رمز التحديث: 20231012
مُعرف محوري في PubMed: PMC9890652
DOI: 10.1039/d2md00119e
PMID: 36760736
قاعدة البيانات: MEDLINE
الوصف
تدمد:2632-8682
DOI:10.1039/d2md00119e